000
| 02071cam 2200361zi 4500 |
---|
001 | 9.944589 |
---|
003 | CaOODSP |
---|
005 | 20241206084526 |
---|
006 | m o d f |
---|
007 | cr cn |||||||| |
---|
008 | 241029e202410 onc ob f000 0 eng d |
---|
020 | |a9780660742267 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH164-383/2024E-PDF |
---|
245 | 00|aGuidance on advertising nicotine replacement therapies. |
---|
264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cOctober 2024. |
---|
264 | 4|c©2024 |
---|
300 | |a1 online resource (iii, 11 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Lignes directrices sur la publicité pour les thérapies de remplacement de la nicotine. |
---|
500 | |a"Pub.: 240592." |
---|
504 | |aIncludes bibliographical references (page 11). |
---|
520 | |a"This guidance document will help industry meet their advertising-related obligations under the Supplementary Rules Respecting Nicotine Replacement Therapies Order (the Order). This document also gives guidance to Health Canada staff on how relevant mandates and objectives should be met fairly, consistently and effectively. Advertising preclearance agencies may use this guidance to inform their internal practices and the services they provide to industry"--Purpose, page 1. |
---|
650 | 0|aSmoking cessation|xLaw and legislation|zCanada. |
---|
650 | 0|aSmoking cessation products|xGovernment policy|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
775 | 08|tLignes directrices sur la publicité pour les thérapies de remplacement de la nicotine.|w(CaOODSP)9.944590 |
---|
856 | 40|qPDF|s434 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-383-2024-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/advertising-nicotine-replacement-therapies.html |
---|